Update on Reliance Life Sciences

(From DNA India). The Indian group Reliance Life Sciences is a well-backed portion of a large conglomerate, and is forging ahead with stem cell research for regenerative medicine - Indian bureaucrats haven't developed anything as monumentally harmful to progress as the FDA in the US. "RLS also has plans to introduce therapies for cardiac and nerve-related diseases like Alzheimer's and Parkinson's. ... They are under pre-clinical stages and we are awaiting approval for human trials from the department of biotechnology (DBT) ... The efficacy of the therapies for neuro-degenerative diseases like Parkinson's and Alzheimer's has been successfully identified in pre-clinical trials ... The stem cell therapy developed by Reliance for the treatment of cartilage damage associated with osteoarthritis is under research studies and will soon enter the pre-clinical studies."

Link: http://www.dnaindia.com/report.asp?NewsID=1035808


Post a comment; thoughtful, considered opinions are valued. New comments can be edited for a few minutes following submission. Comments incorporating ad hominem attacks, advertising, and other forms of inappropriate behavior are likely to be deleted.

Note that there is a comment feed for those who like to keep up with conversations.